MarketScreener

Glaukos Corporation Announces Positive Topline Results From Phase 4 Prospective Randomized Controlled Clinical Trial Evaluating iDose TR In Combination With Cataract Surgery

Glaukos Corporation announced positive topline results from the Phase 4 prospective, randomized, controlled clinical trial (GLK-101-04) evaluating iDose® TR administered in conjunction with cataract ...

ANI Pharmaceuticals Announces Positive Phase 4 Open-Label, Single-Arm SYNCHRONICITY Clinical Trial Results Presented as Late Breaking Oral Presentation at the American Academy ...

Trial met both co-primary endpoints of mean change from baseline in BCVA letter score and mean change from baseline in CST with statistical ...
RTTNews

Takeda Reports Positive New Data Of VERDICT Phase 4 ENTYVIO Trial In Ulcerative Colitis

Japan's Takeda Pharmaceutical Co. Ltd. ( TAK ,4502.T) announced Monday positive new data from VERDICT (NCT04259138), a Phase 4 ENTYVIO clinical trial, in ulcerative colitis or UC-related complication.
Medical Xpress

Clinical trial shows tezepelumab controls asthma in diverse patient population

PASSAGE was designed as a phase 4, multicenter clinical trial to evaluate its use in a broader patient population. Researchers enrolled 286 adults and adolescents in the study, and patients were ...
MarketScreener

Glaukos Announces Positive Topline Results from Phase 4 Prospective Randomized Controlled Clinical Trial Evaluating iDose® TR in Combination with Cataract Surgery

iDose TR also demonstrated a favorable safety profile through 3 months, with no treated-related adverse events of corneal endothelial cell loss or cystoid macular edema (CME), and no serious corneal ...